Article
Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes.
Nature genetics - 1 Nov 2024
Huerta-Chagoya Alicia, Schroeder Philip, Mandla Ravi, Li Jiang, Morris Lowri, Vora Maheak, Alkanaq Ahmed, Nagy Dorka, Szczerbinski Lukasz, Madsen Jesper G S, Bonàs-Guarch Silvia, Mollandin Fanny, Cole Joanne B, Porneala Bianca, Westerman Kenneth, Li Josephine H, Pollin Toni I, Florez Jose C, Gloyn Anna L, Carey David J, Cebola Inês, Mirshahi Uyenlinh L, Manning Alisa K, Leong Aaron, Udler Miriam, Mercader Josep M
Abstract excerpt
Type 2 diabetes (T2D) genome-wide association studies (GWASs) often overlook rare variants as a result of previous imputation panels' limitations and scarce whole-genome sequencing (WGS) data. We used TOPMed imputation and WGS to conduct the largest T2D GWAS meta-analysis involving 51,256 cases of T2D and 370,487 controls, targeting variants with a minor allele frequency as low as 5 × 10-5. We identified 12 new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
